CoChat

Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart

Open access

The DOI matches its Crossref record; 334 of the 340 references it cites were found in a registry or an index.

Abstract

Despite the significant decline in mortality, cardiovascular diseases are still the leading cause of death worldwide. Among them, myocardial infarction (MI) seems to be the most important. A further decline in the death rate may be achieved by the introduction of molecularly targeted drugs. It seems that the components of the PI3K/Akt signaling pathway are good candidates for this. The PI3K/Akt pathway plays a key role in the regulation of the growth and survival of cells, such as cardiomyocytes. In addition, it has been shown that the activation of the PI3K/Akt pathway results in the alleviation of the negative post-infarct changes in the myocardium and is impaired in the state of diabetes. In this article, the role of this pathway was described in each step of ischemia and subsequent left ventricular remodeling. In addition, we point out the most promising substances which need more investigation before introduction into clinical practice. Moreover, we present the impact of diabetes and widely used cardiac and antidiabetic drugs on the PI3K/Akt pathway and discuss the molecular mechanism of its effects on myocardial ischemia and left ventricular remodeling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11091553

Cites

334 of 334 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic of components and mechanisms of PI3K/Akt activation and regulation (a). PI3K/Akt pathway regulates cell death during MI (b). PI3K/Akt signaling is a key component in the regulation of numerous processes in the peri-infarct period and post-infarction remodeling of the left ventricle (c). Akt—protein kinase B, Bax—Bcl-2-associated X protein, Bcl-xL—B-cell lymphoma-extra large, Bcl-2—B-cell lymphoma 2, c—cytochrome c, DNA-PK—DNA-dependent protein kinase, GFs—growth factors, GPX4—glutathione peroxidase 4, GSK3β—glycogen synthase kinase 3 β, IKKα—IκB kinase α, IL-1β, IL-18—interleukins 1β and 18, IRS—insulin receptor substrate, JNK—c-Jun NH2-terminal kinase, MAPK—mitogen-activated protein kinase, MUFA—monounsaturated fatty acids, MLKL—mixed lineage kinase domain-like protein, mTORC1, mTORC2—mammalian target of rapamycin complex 1 and 2, NF-κB—nuclear factor κ-light-chain-enhancer of activated B cells, NLR—NOD-like receptor, P—phosphate, PDK1—phosphoinositide-dependent kinase-1, PHLPP—pleckstrin homology domain leucine-rich repeat protein phosphatase, PIP2—phosphatidylinositol-4,5-bisphosphate, PIP3—phosphatidylinositol-3,4,5-trisphosphate, PI3K—phosphoinositide 3-kinase, PPARβ/ɣ—peroxisome proliferator-activated receptor β/ɣ, PP2A—protein phosphatase 2, PTEN—phosphatase and tensin homolog, RIP1, RIP3—receptor-interacting protein 1 and 3, RTK—receptor tyrosine kinase, SCD1—stearoyl-CoA desaturase-1, SREBP1—sterol regulatory element-binding protein-1, S6K1—ribosomal S6 kinase-1, TNFα—tumor necrosis factor α, TNFR—tumor necrosis factor receptor, 4EBPs—eukaryotic translation initiation factor 4E-binding protein 1.
Figure 1 Schematic of components and mechanisms of PI3K/Akt activation and regulation (a). PI3K/Akt pathway regulates cell death during MI (b). PI3K/Akt signaling is a key component in the regulation of numerous processes in the peri-infarct period and post-infarction remodeling of the left ventricle (c). Akt—protein kinase B, Bax—Bcl-2-associated X protein, Bcl-xL—B-cell lymphoma-extra large, Bcl-2—B-cell lymphoma 2, c—cytochrome c, DNA-PK—DNA-dependent protein kinase, GFs—growth factors, GPX4—glutathione peroxidase 4, GSK3β—glycogen synthase kinase 3 β, IKKα—IκB kinase α, IL-1β, IL-18—interleukins 1β and 18, IRS—insulin receptor substrate, JNK—c-Jun NH2-terminal kinase, MAPK—mitogen-activated protein kinase, MUFA—monounsaturated fatty acids, MLKL—mixed lineage kinase domain-like protein, mTORC1, mTORC2—mammalian target of rapamycin complex 1 and 2, NF-κB—nuclear factor κ-light-chain-enhancer of activated B cells, NLR—NOD-like receptor, P—phosphate, PDK1—phosphoinositide-dependent kinase-1, PHLPP—pleckstrin homology domain leucine-rich repeat protein phosphatase, PIP2—phosphatidylinositol-4,5-bisphosphate, PIP3—phosphatidylinositol-3,4,5-trisphosphate, PI3K—phosphoinositide 3-kinase, PPARβ/ɣ—peroxisome proliferator-activated receptor β/ɣ, PP2A—protein phosphatase 2, PTEN—phosphatase and tensin homolog, RIP1, RIP3—receptor-interacting protein 1 and 3, RTK—receptor tyrosine kinase, SCD1—stearoyl-CoA desaturase-1, SREBP1—sterol regulatory element-binding protein-1, S6K1—ribosomal S6 kinase-1, TNFα—tumor necrosis factor α, TNFR—tumor necrosis factor receptor, 4EBPs—eukaryotic translation initiation factor 4E-binding protein 1.CC BY · PubMed Central
Figure 2 The processes regulated by the PI3K/Akt pathway which are involved in the histologic evolution of acute myocardial infarction. Stage I—histologic changes and processes directly induced by ischemia, stage II—beginning of inflammatory process, stage III and post-infarct left ventricular remodeling—irreversible histologic changes in the myocardium such as collagen secretion. ECM—extracellular matrix, HF—heart failure.
Figure 2 The processes regulated by the PI3K/Akt pathway which are involved in the histologic evolution of acute myocardial infarction. Stage I—histologic changes and processes directly induced by ischemia, stage II—beginning of inflammatory process, stage III and post-infarct left ventricular remodeling—irreversible histologic changes in the myocardium such as collagen secretion. ECM—extracellular matrix, HF—heart failure.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

4 retracted

Show all 334 references

Research works printed but not linked: 1

  1. Yan, 2018, miRNA145 inhibits myocardial infarctioninduced apoptosis through autophagy via Akt3/mTOR signaling pathway in vitro and in vivo, Int. J. Mol. Med., 42, 1537

Cited by

See all 117

Metadata

Authors
Walkowski, B., Kleibert, M., Majka, M., & Wojciechowska, M.
Affiliations
Medical University of Warsaw (PL)
Corresponding author
  • Kleibert, Marcin
  • Majka, Miłosz
Venue
Cells
Publisher
MDPI AG
Published
2022-05-05
Volume
11
Issue
9
Pages
1553
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4280571486
Cited by
117
References
340
Citations by year
2026: 27 · 2025: 31 · 2024: 28 · 2023: 28 · 2022: 3
FWCI
4.58
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Publishing Fund of the Medical University of Warsaw (1MA/N/2022)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
PI3K/Akt signaling, myocardial ischemia, myocardial infarction, diabetic cardiomyopathy, diabetic heart, cardiomyocyte survival, molecularly targeted agents, antidiabetic drugs, cardiovascular drugs
MeSH terms
Diabetes Mellitus, Humans, Myocardial Infarction, Apoptosis, Phosphatidylinositol 3-Kinases, Ventricular Remodeling, Myocytes, Cardiac, Proto-Oncogene Proteins c-akt

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart. https://app.cochat.ai/papers/10.3390/cells11091553
The paper
Walkowski, B., Kleibert, M., Majka, M., & Wojciechowska, M. (2022). Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart. Cells. https://doi.org/10.3390/cells11091553

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.